戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 1486466作成日:2026年10月26日

Acetamide → 3,5-Diiodothyronine, L-

https://huagongshe.com/reaction/1486466

反応式

関与物質

役割名称HCID仕込み量
反応物AcetamideHCID 178—
反応物Hydrogen BromideHCID 260—
反応物Dimethyl EtherHCID 8254—
反応物Hydrogen iodideHCID 24841—
反応物L-Tyrosine, N-acetyl-3,5-diiodo-O-(4-methoxyphenyl)-, ethyl esterHCID 10952191—
生成物3,5-Diiodothyronine, L-HCID 92859—

反応手順

Many patent and non-patent literature describe the use of an intermediate called Bis (p-anisyl)iodonium bromide in the preparation of Levothyroxine sodium. Hillmann (Z. Naturforch 1956; 11b:424-425) describes a process for the assembly of the biphenyl-ether system present in Levothyroxine, wherein a key coupling reaction is initiated between N-Acetyl 3,5-diiodo-L-tyrosine ethyl ester, derived from the stepwise protective conversion of amine as amide and acid as ester of 3,5 diido-L-tyrosine, and Bis (p-anisyl)iodonium bromide in the presence of copper metal or powder as a catalyst to afford (S)—N-acetyl-3,5-diiodo-4-p-methoxyphenoxyphenylalanine ethyl ester, with 87% yield. All the three protective groups in (S)—N-acetyl-3,5-diiodo-4-p-methoxyphenoxyphenylalanine ethyl ester, viz. acetamide, methyl ether, ethyl ester were cleaved using a mixture of Hydroiodic acid and Hydrobromic acid to give 3,5-Diiodothyronine. 3,5-Diiodothyronine on subsequent iodination with iodine gave L-thyroxine of an yield that corresponds to 92%.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US09428444B2
出典データセットuspto-grants-2016_08
ORD IDord-19dc8d269fa84dfbaa970919e8c7f67c
出典メモuspto-grants-2016_08